|
"Statistical Methods for Genetic Epidemiology"
|
5R01CA094069-09
|
$580,133
|
$191,444
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
|
5R01CA205965-02
|
$640,839
|
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
5R01CA206025-03
|
$630,724
|
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
|
5R01CA205258-03
|
$464,261
|
|
GUDAS, LORRAINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-03
|
$703,249
|
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
5R01CA206026-03
|
$356,850
|
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
|
5R01CA206483-02
|
$570,958
|
|
EMU, BRINDA
|
YALE UNIVERSITY
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-03
|
$706,386
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer
|
5R01CA206465-03
|
$512,833
|
|
JUSTICE, AMY
|
YALE UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-04
|
$334,291
|
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
5R01CA217138-02
|
$723,817
|
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
|
5R01CA216273-02
|
$740,321
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-04
|
$446,627
|
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-04
|
$525,066
|
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
|
5R01CA194697-04
|
$347,700
|
|
ZHANG, SIYUAN
|
UNIVERSITY OF NOTRE DAME
|
|
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
|
5R01CA197103-03
|
$584,861
|
|
SCHENKER, YAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A High-Throughput Model for Human Melanoma
|
5R01CA121118-10
|
$247,340
|
|
HOLMEN, SHERI
|
UNIVERSITY OF UTAH
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
5R01CA174851-05
|
$511,226
|
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A microRNA mediating vascular directed fibrinolysis and tumor progression
|
5F31CA213793-03
|
$33,794
|
|
MCCANN, JAMES
|
UNIVERSITY OF VIRGINIA
|
|
A mobile app to reduce treatment-related financial burden for cancer patients
|
5R42CA210699-03
|
$502,303
|
|
ZAFAR, SYED
|
VIVOR, LLC
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-04
|
$286,758
|
$43,014
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A near-infrared contrast agent for targeted imaging of cancer
|
5K25CA120350-04
|
$141,776
|
$141,776
|
Romanowski, Marek
|
UNIVERSITY OF ARIZONA
|
|
A new imaging approach to radiotherapy planning for lung cancer
|
5R01CA193050-04
|
$577,910
|
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers
|
1R21CA137681-01A1
|
$204,233
|
$204,233
|
CHILES, THOMAS
|
BOSTON COLLEGE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Phase I trial combining IV fenretinide and IV safingol to target overproduction
|
5R44CA183316-03
|
$473,425
|
|
SIMPSON, WILLIAM
|
CERRX, INC.
|
|
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY
|
5R01CA051578-18
|
$236,153
|
$236,153
|
KOPECEK, JINDRICH
|
UNIVERSITY OF UTAH
|
|
A Pooled Analysis to Identify New Ovarian Cancer Risk Factors
|
5R01CA136891-02
|
$333,819
|
$333,819
|
PEARCE, CELESTE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A role for notch in self renewal in embryonal rhabdomyosarcoma
|
5R00CA175184-04
|
$249,000
|
|
IGNATIUS, MYRON
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc
|
5R01CA134424-02
|
$420,959
|
$420,959
|
KOSTUK, RAYMOND
|
UNIVERSITY OF ARIZONA
|
|
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display
|
5R21CA204708-02
|
$191,186
|
$95,593
|
MALMSTADT, NOAH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases
|
5R21CA214299-02
|
$181,477
|
|
SLATER, JOHN
|
UNIVERSITY OF DELAWARE
|
|
A versatile high-performance optical mammography co-imager
|
5R01CA204443-03
|
$343,021
|
|
FANG, QIANQIAN
|
NORTHEASTERN UNIVERSITY
|
|
Aberrant DNA methylation patterns of miRNAs and breast cancer racial disparities
|
5K07CA178293-05
|
$143,992
|
|
GONG, ZHIHONG
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Academic Training in Medical Oncology
|
5T32CA009297-27
|
$304,451
|
$30,445
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
3R01CA133148-03S1
|
$57,473
|
$14,368
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
5R01CA133148-03
|
$431,379
|
$107,845
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
Accelerating Cancer Genomics with Cloud-scale Bioconductor
|
5U01CA214846-02
|
$438,654
|
|
CAREY, VINCENT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Achieving Excellence in Biopsychosocial Cancer Pain Management through a Comprehensive Quality Education Program
|
1R25CA225485-01
|
$262,605
|
|
DY, SYDNEY
|
JOHNS HOPKINS UNIVERSITY
|
|
Adaptive regulation of cancer cell fate following oncogene inhibition
|
5R00CA194163-04
|
$249,000
|
|
FALLAHI-SICHANI, MOHAMMAD
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-015
|
$228,267,549
|
$22,500
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Addressing ELSI Issues in Unregulated Health Research Using Mobile Devices
|
5R01CA207538-02
|
$247,350
|
|
ROTHSTEIN, MARK
|
UNIVERSITY OF LOUISVILLE
|
|
Adult Brain Tumor Consortium (ABTC)
|
5UM1CA137443-09
|
$1,244,620
|
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Advanced Development of an Open-source Platform for Web-based Integrative Digital Image Analysis in Cancer
|
5U24CA194362-04
|
$687,048
|
|
GUTMAN, DAVID
|
EMORY UNIVERSITY
|
|
Affinity-directed tagging of protein binding partners in signaling
|
5R01CA191018-05
|
$328,888
|
|
WELLS, JAMES
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
ALK Rearrangements in Aggressive Thyroid Cancer
|
5R01CA181150-05
|
$313,721
|
|
NIKIFOROV, YURI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Alpha-Catenin in Regulation of Tissue Homeostasis and Cancer
|
5R01CA179914-05
|
$436,778
|
|
VASIOUKHIN, VALERI
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Altered Proteoglycan Gene Expression and Cancer
|
5R01CA039481-31
|
$379,604
|
|
IOZZO, RENATO
|
THOMAS JEFFERSON UNIVERSITY
|
Total relevant funding to Ovarian Cancer for this search: $113,569,125
|